🇺🇸 FDA
Pipeline program

Narcan 40 MG/ML Nasal Spray

P21.112

Phase 1 small_molecule active

Quick answer

Narcan 40 MG/ML Nasal Spray for Opioid Induced Respiratory Depression is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid Induced Respiratory Depression
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials